Progressing Biotherapeutics to Clinic Faster Biological activity of a biotherapeutic is a Critical Quality Attribute (CQA), which needs to be accur

Eurofins DiscoverX, in conjunction with Drug Target Review, sponsored and moderated a Bioassay roundtable discussion webinar with group leaders fro

Cytokines and their receptors have emerged as major drug targets for inflammatory and autoimmune diseases, allergies, and, more recently, in cancer

Glucagon-like peptides, GLP-1 & GLP-2, are well-researched, metabolically significant peptide hormones secreted from the L-cells of the small

Functional, cell-based assays for analyzing cytokine signaling

Whether you’re looking to screen a library of drug candidates for binding to a particular target protein, checking drug cell membrane penetration,

Learn about a new cellular target engagement platform that can verify a drug reaches the intended organ or tissue and engages a specific target.

Most therapeutic antibodies have a Fab’ region that binds the antigen, and an Fc region which binds to and activates various cell surface receptors

Read this article to discover the benefits, challenges, and overall workflow for generating successful cell-based assays on your own.

Class I therapeutic antibodies achieve their clinical efficacy not only by binding to their target antigen but also through Fc domain-mediated recr

Eurofins DiscoverX delivers enabling technologies and the most comprehensive portfolio of established biochemical and cell-based assays, cell lines

Drugs interact with living physiology; an in vitro assay of drug activity can be considered a snapshot of the full movie seen in vivo<